Hexokinase domain-containing protein 1 (HKDC1) is an enzyme crucially involved in glucose metabolism, specifically in the first step of glycolysis where it catalyzes the phosphorylation of glucose to glucose-6-phosphate. This enzymatic reaction is essential for trapping glucose within the cell and initiating its metabolic processing. HKDC1 is expressed in various tissues, including skeletal muscle, liver, and adipose tissue, where it plays a fundamental role in regulating glucose uptake and utilization. By facilitating the conversion of glucose to glucose-6-phosphate, HKDC1 serves as a key regulatory point in glycolysis, influencing downstream metabolic pathways such as the citric acid cycle and oxidative phosphorylation. Moreover, HKDC1 expression levels and activity are tightly regulated in response to cellular energy demands and nutrient availability, ensuring efficient glucose utilization and energy production.
The activation of HKDC1 is intricately regulated by multiple mechanisms that modulate its enzymatic activity, expression levels, and subcellular localization. One crucial aspect of HKDC1 activation involves its interaction with regulatory proteins and metabolites that influence its catalytic function. For instance, glucose binding to HKDC1 allosterically activates the enzyme, enhancing its ability to phosphorylate glucose molecules. Additionally, post-translational modifications such as phosphorylation and acetylation may regulate HKDC1 activity and subcellular localization, further modulating its function in glucose metabolism. Furthermore, transcriptional regulation of HKDC1 gene expression by transcription factors and signaling pathways also contributes to its activation, ensuring appropriate levels of enzyme synthesis in response to cellular metabolic demands. Overall, the intricate mechanisms governing HKDC1 activation highlight its critical role in glucose metabolism and cellular energy homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor, increases acetylation levels on histones, potentially influencing the structure and function of chromatin including Histone H2BM. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Another histone deacetylase inhibitor, promotes acetylation, potentially affecting Histone H2BM and chromatin accessibility. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase inhibitor, affects gene expression by altering histone acetylation, potentially impacting Histone H2BM. | ||||||
Methylstat | 1310877-95-2 | sc-507374 | 10 mg | $480.00 | ||
A histone methyltransferase inhibitor, could indirectly influence the methylation status of Histone H2BM. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methyltransferases, leading to changes in DNA methylation and potentially influencing histone modification patterns including H2BM. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
Another DNA methyltransferase inhibitor, alters DNA methylation, potentially impacting histone modification and H2BM activity. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $36.00 $110.00 $400.00 | ||
A G9a histone methyltransferase inhibitor, could affect histone methylation, indirectly influencing Histone H2BM. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
A natural compound that can affect various signaling pathways and potentially influence histone modifications and H2BM activity. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
Inhibits BET bromodomains, potentially influencing chromatin structure and indirectly affecting Histone H2BM. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Inhibits histone acetyltransferase, which could indirectly influence the acetylation status of Histone H2BM. |